Home
NSE: AKUMS
Market Cap
NSE: AKUMS
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 625.35 | 600.1 | 627.85 | 600.1 |
13 Jan 2025 | 607.65 | 601.35 | 629.4 | 595.45 |
10 Jan 2025 | 617.35 | 612.05 | 631.35 | 608.25 |
09 Jan 2025 | 618 | 636.85 | 636.85 | 607.6 |
08 Jan 2025 | 625.05 | 604 | 651 | 604 |
07 Jan 2025 | 611.75 | 608.8 | 621.35 | 608.8 |
06 Jan 2025 | 608.75 | 632.85 | 637.7 | 603 |
03 Jan 2025 | 633.75 | 644.85 | 652 | 630.85 |
02 Jan 2025 | 641 | 633.55 | 645 | 622.85 |
01 Jan 2025 | 633.5 | 645 | 647.7 | 628.4 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 625.35 |
13 Jan 2025 | 607.65 |
10 Jan 2025 | 617.35 |
09 Jan 2025 | 618 |
08 Jan 2025 | 625.05 |
07 Jan 2025 | 611.75 |
06 Jan 2025 | 608.75 |
03 Jan 2025 | 633.75 |
02 Jan 2025 | 641 |
01 Jan 2025 | 633.5 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical P/E Ratio of Akums Drugs & Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical Revenue of Akums Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical EBITDA of Akums Drugs & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has
Read more
2024-08-06 00:00:00
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha
Read more
2024-08-02 00:00:00
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha
Read more
2024-08-01 00:00:00
Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202
Read more
2024-08-26 00:00:00